OCS
Oculis Holding AG Ordinary shares
stock NASDAQ

Oculis Reports Q1 Financial Results and Provides Company Update - OCS OCSAW

https://preview.redd.it/31uw8qfi7kze1.png?width=2148&format=png&auto=webp&s=b13f88aaac4460443158d1744afbe5895ad3e21a
Good morning, SqueezeFinders!
Another volatile day in the books as Jerome Powell carried us through yet another dramatic FOMC trading session just to hear that rates are remaining unchanged, and that the Fed remains “well-positioned” with their tools to handle any challenges that may arise. Jerome said that debt is on an unsustainable path, but not an unsustainable level, so naturally the debt ceiling was lifted. The $QQQ tech index remains just shy of the 200 day moving average near 490. We need to reclaim the resistance level near 485, then the 200 day moving average, and then we can rapidly test the 500 level as resistance. Ideally we can flip the 500 level from resistance back to support in the near future to confirm the resumption of the long-term uptrend. Bulls need to hold support levels at 480 and 477, or we risk resumption of the medium-term downtrend. Trump says a big trade deal with the United Kingdom will be announced tomorrow, which has prompted an overnight spike in $QQQ of \~0.7% to \~487. Let’s see if this momentum carries over into today’s intraday session. Regardless of broader market conditions, you can locate relative strength by tapping/clicking on the “Price” column header to sort the live watchlist in descending order of top gainer.
Today's economic data releases are:
🇺🇸 Initial Jobless Claims @ 8:30AM ET
🇺🇸 Unit Labour Costs (Q1) @ 8:30AM ET
🇺🇸 Nonfarm Productivity (Q1) @ 8:30AM ET
🇺🇸 Continuing Jobless Claims @ 8:30AM ET
🇺🇸 30Y Bond Auction @ 1PM ET
🇺🇸 Atlanta Fed GDPNow (Q2) @ 1PM ET
🇺🇸 Fed’s Balance Sheet @ 4:30PM ET
📙Breakdown point: BELOW this price, the move will lose momentum significantly in the short-term, as shorts will gain confidence encouraging them to short more. Reducing probability of a squeeze without a catalyst.
📙Breakout point: ABOVE this price, the move will gain momentum significantly in the short-term, as shorts losses will increase pressuring them to cover. Increasing the probability of a squeeze occurring, especially if with a catalyst.
4. $TEM
Squeezability Score: 60%
Juice Target: 139.3
Confidence: 🍊 🍊
Price: 58.76 (+12.6%)
Breakdown point: 50.0
Breakout point: 61.5
Mentions (30D): 4
Event/Condition: Potentially imminent medium-term downtrend bullish reversal and cup & handle technical pattern playing out on short-term timeframe with breakout near 61.5 + Company recently announced $200M multi-year deal with AstraZeneca, PathosAI (on top of pre-existing $320M partnership with AstraZeneca) + New price target 🎯 of $60 from BTIG + Recent price target 🎯 of $70 from Needham + Company recently acquired Deep 6 AI + Old Pelosi pump play + Recent price target 🎯 of $62 from TD Cowen + Company recently expanded support of phase 1 clinical trials to accelerate activation and enrollment + Company recently launched Notetaker, AI-Powered Clinical Assistant To Aid Psychiatrists In Generating Progress Note.
5. $TMDX
Squeezability Score: 59%
Juice Target: 267.3
Confidence: 🍊 🍊
Price: 95.81 (+2.6%)
Breakdown point: 82.0
Breakout point: 99.0
Mentions (30D): 14
Event/Condition: Earnings report TODAY (binary catalyst) + Recent victim of short report from Scorpion Capital + Recent price target 🎯 of $104 from Canaccord Genuity + Recent price target 🎯 of $105 from Piper Sandler + Gap from \~96 to \~126 on daily chart + New price target 🎯 of $120 from TD Cowen + Small rel vol ramp + Potentially imminent 6 month rangebound consolidation breakout if over 99 into gap + Additional commentary from TD Cowen analyst, “Company’s OCS drives structural transformation in live transplantation with increased DCD liver utilization.”
To gain access to all our cutting-edge research tools, live watchlists, alerts, and more: [http://www.squeeze-finder.com/subscribe](http://www.squeeze-finder.com/subscribe)
HINT: Use code RDDT for a free week!

Oculis Reports Q1 Financial Results and Provides Company Update - OCS OCSAW

https://preview.redd.it/31uw8qfi7kze1.png?width=2148&format=png&auto=webp&s=b13f88aaac4460443158d1744afbe5895ad3e21a
Good morning, SqueezeFinders!
Another volatile day in the books as Jerome Powell carried us through yet another dramatic FOMC trading session just to hear that rates are remaining unchanged, and that the Fed remains “well-positioned” with their tools to handle any challenges that may arise. Jerome said that debt is on an unsustainable path, but not an unsustainable level, so naturally the debt ceiling was lifted. The $QQQ tech index remains just shy of the 200 day moving average near 490. We need to reclaim the resistance level near 485, then the 200 day moving average, and then we can rapidly test the 500 level as resistance. Ideally we can flip the 500 level from resistance back to support in the near future to confirm the resumption of the long-term uptrend. Bulls need to hold support levels at 480 and 477, or we risk resumption of the medium-term downtrend. Trump says a big trade deal with the United Kingdom will be announced tomorrow, which has prompted an overnight spike in $QQQ of \~0.7% to \~487. Let’s see if this momentum carries over into today’s intraday session. Regardless of broader market conditions, you can locate relative strength by tapping/clicking on the “Price” column header to sort the live watchlist in descending order of top gainer.
Today's economic data releases are:
🇺🇸 Initial Jobless Claims @ 8:30AM ET
🇺🇸 Unit Labour Costs (Q1) @ 8:30AM ET
🇺🇸 Nonfarm Productivity (Q1) @ 8:30AM ET
🇺🇸 Continuing Jobless Claims @ 8:30AM ET
🇺🇸 30Y Bond Auction @ 1PM ET
🇺🇸 Atlanta Fed GDPNow (Q2) @ 1PM ET
🇺🇸 Fed’s Balance Sheet @ 4:30PM ET
📙Breakdown point: BELOW this price, the move will lose momentum significantly in the short-term, as shorts will gain confidence encouraging them to short more. Reducing probability of a squeeze without a catalyst.
📙Breakout point: ABOVE this price, the move will gain momentum significantly in the short-term, as shorts losses will increase pressuring them to cover. Increasing the probability of a squeeze occurring, especially if with a catalyst.
4. $TEM
Squeezability Score: 60%
Juice Target: 139.3
Confidence: 🍊 🍊
Price: 58.76 (+12.6%)
Breakdown point: 50.0
Breakout point: 61.5
Mentions (30D): 4
Event/Condition: Potentially imminent medium-term downtrend bullish reversal and cup & handle technical pattern playing out on short-term timeframe with breakout near 61.5 + Company recently announced $200M multi-year deal with AstraZeneca, PathosAI (on top of pre-existing $320M partnership with AstraZeneca) + New price target 🎯 of $60 from BTIG + Recent price target 🎯 of $70 from Needham + Company recently acquired Deep 6 AI + Old Pelosi pump play + Recent price target 🎯 of $62 from TD Cowen + Company recently expanded support of phase 1 clinical trials to accelerate activation and enrollment + Company recently launched Notetaker, AI-Powered Clinical Assistant To Aid Psychiatrists In Generating Progress Note.
5. $TMDX
Squeezability Score: 59%
Juice Target: 267.3
Confidence: 🍊 🍊
Price: 95.81 (+2.6%)
Breakdown point: 82.0
Breakout point: 99.0
Mentions (30D): 14
Event/Condition: Earnings report TODAY (binary catalyst) + Recent victim of short report from Scorpion Capital + Recent price target 🎯 of $104 from Canaccord Genuity + Recent price target 🎯 of $105 from Piper Sandler + Gap from \~96 to \~126 on daily chart + New price target 🎯 of $120 from TD Cowen + Small rel vol ramp + Potentially imminent 6 month rangebound consolidation breakout if over 99 into gap + Additional commentary from TD Cowen analyst, “Company’s OCS drives structural transformation in live transplantation with increased DCD liver utilization.”
To gain access to all our cutting-edge research tools, live watchlists, alerts, and more: [http://www.squeeze-finder.com/subscribe](http://www.squeeze-finder.com/subscribe)
HINT: Use code RDDT for a free week!